This Month in Psychopharmacology

Browsing articles in "Additional Neurology Topics"

'Convincing Evidence' Hearing Aids Reduce Dementia Risk
December 20, 2022

With no truly effective treatment for dementia yet available, there is increased interest in lifestyle factors that may delay or prevent the onset of dementia. Previous studies have shown that hearing loss is associated with increased risk of dementia and cognitive decline. There are 3 main hypotheses for this association...

Imaging IDs Brain Activity Related to Dissociative Symptoms
November 24, 2022

In a study of nearly 100 women, participants with certain dissociative symptoms had increased connections within some brain networks and decreased connections within others. The new findings shed light on the brain connectivity associated with these debilitating symptoms and ultimately may help clinicians diagnose and treat affected patients....

Continue reading (Members only)

Antidepressants in Pregnancy Aren't Linked to Increased Neurological Issues in Children
October 16, 2022

In a recent cohort study, the relationship between in utero exposure to antidepressants and increased risk of neurodevelopmental disorders was examined...

ADHD and Risk of Migraine
July 5, 2022

A recent longitudinal case-cohort study shows children and adolescents with ADHD were associated with an increased risk of migraine compared with matched controls. Results showed that children and adolescents with ADHD were associated with an increased risk of migraine compared with...

Continue reading (Members only)

Role Of The Oral-Gut-Microbiome-Brain Axis In Trauma-Related Disorders
February 23, 2022

The microbiome-gut-brain axis has been proposed as a moderator or mediator for posttraumatic stress disorder (PTSD). However, clinical data about this direct relationship are lacking. In a recent cohort study, the associations between the gut microbiome and mental health outcomes...

Continue reading (Members only)

Psilocybin Therapy Increases Cognitive And Neural Flexibility In Patients With Major Depressive Disorder
November 18, 2021

Psilocybin therapy has shown promise in treating major depressive disorder and other psychiatric illnesses. However, the cognitive and neural mechanisms underlying its enduring efficacy is poorly understood. An open-label study examined the enduring effects of psilocybin therapy on the cognitive and neural flexibility...

2021 NEI Congress Young Investigator Poster Competition Winners
November 5, 2021

The 2021 NEI Congress Scientific Poster Session and Reception was held on Friday, November 5th and featured 67 posters, with an additional 48 posters presented virtually, covering the full spectrum of mental health research and clinical data. Among them, three particularly stood out for the quality of their data and contributions to the field, and...

Fluoxetine and Post-Stroke Depression
August 30, 2021

One in 3 adults suffer clinically significant symptoms of depression for the first year following a stroke. There is limited evidence that supports the use of antidepressants in this population. A recent parallel-group, randomized, double-blind...

Continue reading (Members only)

Psychotropic Polypharmacy Prevalent in Patients With Dementia
March 25, 2021

Dementia is increasingly prevalent as the population ages. In addition to memory deficits, patients with dementia often exhibit other neuropsychiatric symptoms that can be disturbing to caregivers and increase the likelihood of institutionalization. It is therefore not uncommon for patients with dementia to be prescribed psychotropic agents despite...

Continue reading (Members only)

Task Force Tackles FDA Lamotrigine Cardiac Risk Warning
March 12, 2021

Recently, the International League Against Epilepsy and the American Epilepsy Society Task Force met to discuss the food and drug administration warning on the cardiac effects of lamotrigine. These concerns originated from lamotrigine’s sodium channel blocking properties....

Top of Page